Business
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing
GERMANTOWN, Md. & VENLO, Netherlands, September 02, 2025--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAstat‑Dx Rise – a version of the QIAstat-Dx automated syndromic testing system that offers unparalled throughput with the easiest workflow available to customers worldwide.
About this update from Qiagen N.v.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":242,"height":204,"url":"https://media.zenfs.com/en/business-wire.com/8acf7495ff8a3b62d1efc52df196ccfe"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/RpEp6Im2ebKX02LZeKmOqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM1NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/8acf7495ff8a3b62d1efc52df196ccfe","width":242,"height":204}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"U.S. market entry set to begin for QIAstat-Dx Rise – a version of QIAstat-Dx for syndromic testing that combines unparalleled throughput with the easiest workflow","length":162,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"QIAstat-Dx Rise launch can process up to 160 samples per day, initial launch includes Respiratory Panel Plus and Respiratory Panel Mini and additional panels in development","length":172,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Expansion of QIAstat-Dx instrument portfolio in the U.S. builds on the availability of both system options in Europe and other regions of the world","length":147,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":481,"olType":false},{"type":"text","content":"GERMANTOWN, Md. & VENLO, Netherlands, September 02, 2025--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAstat‑Dx Rise – a version of the QIAstat-Dx automated syndromic testing system that offers unparalled throughput with the easiest workflow available to customers worldwide.","length":339,"tagName":"p"},{"type":"text","content":"The new system, which received clearance from the U.S. Food and Drug Administration (FDA), is designed to meet the needs of hospitals and reference laboratories seeking highly automated syndromic testing with automated loading and unloading of cartridges, access to priority handling of urgent samples and only a minimum of hands-on time.","length":338,"tagName":"p"},{"type":"text","content":""The launch of QIAstat-Dx Rise marks a significant step forward in our commitment to expand access to infectious disease diagnostics across the U.S., and builds on the expansion efforts for this system in other areas of the world," said Nadia Aelbrecht, Vice...